EGFR-Mutated Lung Cancer With T790M-Acquired Resistance in the Brain and Histologic Transformation in the Lung

被引：31

作者：

Scher, Kevin S. ^{[1
]}

Saldivar, Juan-Sebastian ^{[1
]}

Fishbein, Michael ^{[2
]}

Marchevsky, Alberto ^{[3
]}

Reckamp, Karen L. ^{[1
]}

机构：

[1] City Hope Comprehens Canc Ctr, Duarte, CA USA

[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA

[3] Cedars Sinai Med Ctr, Hollywood, CA USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2013年 / 11卷 / 09期

关键词：

ERLOTINIB; GEFITINIB;

D O I：

10.6004/jnccn.2013.0126

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

This case report describes the rare occurrence of a T790M resistance mutation found in a central nervous system (CNS) parenchymal metastasis. A concomitant squamous histology transformation in a lung non-T790M-resistant metastasis is also described. The authors hypothesize that this CNS resistance and histology transformation may have resulted from intermittent use of erlotinib treatment. This case report emphasizes the complexities of using erlotinib in the induction setting.

引用

页码：1040 / 1044

页数：5

共 50 条

[31] Encouraging Fussy Eaters in EGFR-Mutated Lung Cancer
Gray, Steven G.
Mutti, Luciano
Meirson, Tomer
JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (08) : 1125 - 1127
[32] Squamous cell carcinoma transformation from adenocarcinoma as an acquired resistance after the EGFR TKI therapy in (EGFR-mutated) non-small cell lung cancer
Shinohara, Shinji
Ichiki, Yoshinobu
Fukuichi, Yukiko
Honda, Yohei
Kanoyama, Masatoshi
Taira, Akihiro
Nabe, Yusuke
Kuwata, Taiji
Takenaka, Masaru
Oka, Soichi
Chikaishi, Yasuhiro
Hirai, Ayako
Imanishi, Naoko
Kuroda, Koji
Yoneda, Kazue
Noguchi, Hirotsugu
Tanaka, Fumihiro
JOURNAL OF THORACIC DISEASE, 2018, 10 (07) : E526 - E531
[33] Cytomorphologic and Molecular Evolution of EGFR-Mutated Lung Adenocarcinomas with Acquired Resistance to Tyrosine Kinase Inhibitors
Doxtader, Erika E.
Brainard, Jennifer A.
Sturgis, Charles D.
Velcheti, Vamsidar
Zhang, Yaxia
LABORATORY INVESTIGATION, 2017, 97 : 93A - 93A
[34] The combination of irreversible EGFR TKIs and SAHA induces apoptosis and autophagy-mediated cell death to overcome acquired resistance in EGFR T790M-mutated lung cancer
Lee, Tae-Gul
Jeong, Eun-Hui
Kim, Seo Yun
Kim, Hye-Ryoun
Kim, Cheol Hyeon
INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (11) : 2717 - 2729
[35] Cytomorphologic and Molecular Evolution of EGFR-Mutated Lung Adenocarcinomas with Acquired Resistance to Tyrosine Kinase Inhibitors
Doxtader, Erika E.
Brainard, Jennifer A.
Sturgis, Charles D.
Velcheti, Vamsidar
Zhang, Yaxia
MODERN PATHOLOGY, 2017, 30 : 93A - 93A
[36] Differential microRNA expression of EGFR T790M mutated and tyrosine kinase inhibitor-sensitive EGFR mutated lung cancer
Lee, C. -H.
Kim, J. -Y.
Lee, W. -J.
Park, H. -Y.
Kim, A.
Shin, D. -H.
VIRCHOWS ARCHIV, 2017, 471 : S111 - S112
[37] Molecular mechanisms of acquired resistance to third-generation EGFR-TKIs in EGFR T790M-mutant lung cancer
Ricordel, C.
Friboulet, L.
Facchinetti, F.
Soria, J. -C.
ANNALS OF ONCOLOGY, 2018, 29 : I28 - I37
[38] Prognostic impact of pretreatment T790M mutation on outcomes for patients with resected, EGFR-mutated, non-small cell lung cancer
Yoshiya Matsumoto
Tomoya Kawaguchi
Masaru Watanabe
Shun-ichi Isa
Masahiko Ando
Akihiro Tamiya
Akihito Kubo
Chiyoe Kitagawa
Naoki Yoshimoto
Yasuhiro Koh
BMC Cancer, 22
[39] Meeting with triumph and disaster: Osimertinib in T790M-unknown CNS progression in EGFR-mutated non-small cell lung cancer
Facchinetti, Francesco
Bozzetti, Francesca
Minari, Roberta
Ceccon, Giovanni
Zielli, Teresa
Florindo, Irene
Crisi, Girolamo
Tiseo, Marcello
TUMORI JOURNAL, 2018, 104 (06): : NP29 - NP33
[40] Combination Osimertinib and Gefitinib in C797S and T790M EGFR-Mutated Non-Small Cell Lung Cancer
Arulananda, Surein
Do, Hongdo
Musafer, Ashan
Mitchell, Paul
Dobrovic, Alexander
John, Thomas
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : 1728 - 1732

← 1 2 3 4 5 →